Vimarsana
Biggest News Aggregation in the World

Page 2 - Biocon Park News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biocon Park. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biocon Park Today - Breaking & Trending Today

Biocon Biologics gets EU GMP Certification for new Biologics manufacturing facility in Bengaluru - Vimarsana News

Biocon Biologics gets EU GMP Certification for new Biologics manufacturing facility in Bengaluru

This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.

Biocon Biologics gets EU GMP certification for new facility in Bengaluru - Vimarsana News

Biocon Biologics gets EU GMP certification for new facility in Bengaluru

The EU Good Manufacturing Practices (GMP) accreditation is offered to pharmaceutical manufacturers who adhere to a minimal standard in their production practices.

Biocon Biologics bags EU GMP certificate for its facility at Biocon Park, Bengaluru - Vimarsana News

Biocon Biologics bags EU GMP certificate for its facility at Biocon Park, Bengaluru

A GMP inspection was conducted in April 2022

Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant - Vimarsana News

Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant

Read more about Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant on Devdiscourse

Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant - Vimarsana News

Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant

Biotechnology major Biocon Biologics on Tuesday said Ireland's health regulator has reported some deficiencies in the manufacturing process at the company's plant in Bengaluru. The Health Products Regulatory Authority (HPRA), Ireland, conducted a GMP (Good Manufacturing Practice) inspection of one of Biocon Biologics' new monoclonal antibody drug substance manufacturing